Quarter Financials
Acorda Therapeutics Inc (ACOR)
$6.7
0.33 (+5.18%)
Retained Earning Schedule
| Year | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 7 | -17 | -6 | 66 | -264 | -27 | -48 | 10 | -14 | 46 | -8 |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - |
| Retained Earnings | -683 | -691 | -673 | -667 | -732 | -469 | -441 | -394 | -403 | -390 | -436 |
PPE Schedule
| Year | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | - | -2 | -2 | -14 | -19 | -33 | -25 | -11 | -12 | -6 | -5 |
| Net PPE | 159 | 163 | 165 | 166 | 155 | 139 | 110 | 61 | 52 | 43 | 39 |
Intangible and Goodwill Schedule
| Year | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| New Purchases | -107 | -42 | -43 | -57 | -49 | -59 | -64 | -55 | - | - | - |
| Intangible and Goodwill | 290 | 284 | 283 | 282 | 280 | 281 | - | - | - | - | - |